Posted on May 6, 20215/6/21
ZIN Rejects Kaftrio Plus Kalydeco, Urges 75% Price Reduction and Renegotiation of All Vertex Drugs
Posted on May 5, 20215/5/21
NICE Extends Clinical Eligibility Criteria for Spinraza
Posted on May 4, 20215/4/21
EFPIA Report Highlights 6 Core Principles to Govern Transparency in Evidence Under Novel Pricing Agreements
Posted on April 28, 20214/28/21
US Onshoring Essential Antibiotics Act Seeks to Re-Localize Production of Essential Antibiotics
Posted on April 26, 20214/26/21
Elijah J. Cummings Lower Drug Costs Now Act (HR 3) Reintroduced in United States
Posted on April 26, 20214/26/21
World EPA Congress DAY 2: Global Trends in Net Price
Posted on April 21, 20214/21/21
Bluebird to Withdraw Zynteglo from Germany After Price Negotiations Failed to Recognize Drug’s Value
Posted on April 21, 20214/21/21
Kymriah, Yescarta Subject to Cost-Effectiveness Assessment-Based Price Adjustments in Japan
Posted on April 20, 20214/20/21
Amgen’s Bemarituzumab Granted Breakthrough Designation in U.S.
Posted on April 20, 20214/20/21